Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 205

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing

Open access
Liu, Pengyuan, Morrison, Carl, Wang, Liang, Xiong, Donghai, Vedell, Peter, Cui, Peng, Hua, Xing, Ding, Feng, Lu, Yan, James, Michael, Ebben, John D., Xu, Haiming, Adjei, Alex A., Head, Karen, Andrae, Jaime W., Tschannen, Michael R., Jacob, Howard, Pan, Jing, Zhang, Qi, Van den Bergh, Francoise, Xiao, Haijie, Lo, Ken C., Patel, Jigar, Richmond, Todd, Watt, Mary-Anne, Albert, Thomas, Selzer, Rebecca, Anderson, Marshall, Wang, Jiang, Wang, Yian, Starnes, Sandra, Yang, Ping, You, Ming·2012·Carcinogenesis

Abstract

Lung cancer is the leading cause of cancer-related death, with non-small cell lung cancer (NSCLC) being the predominant form of the disease. Most lung cancer is caused by the accumulation of genomic alterations due to tobacco exposure. To uncover its mutational landscape, we performed whole-exome sequencing in 31 NSCLCs and their matched normal tissue samples. We identified both common and unique mutation spectra and pathway activation in lung adenocarcinomas and squamous cell carcinomas, two major histologies in NSCLC. In addition to identifying previously known lung cancer genes (TP53, KRAS, EGFR, CDKN2A and RB1), the analysis revealed many genes not previously implicated in this malignancy. Notably, a novel gene CSMD3 was identified as the second most frequently mutated gene (next to TP53) in lung cancer. We further demonstrated that loss of CSMD3 results in increased proliferation of airway epithelial cells. The study provides unprecedented insights into mutational processes, cellular pathways and gene networks associated with lung cancer. Of potential immediate clinical relevance, several highly mutated genes identified in our study are promising druggable targets in cancer therapy including ALK, CTNNA3, DCC, MLL3, PCDHIIX, PIK3C2B, PIK3CG and ROCK2.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/carcin/bgs148

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 205

Metadata

Authors
Liu, P., Morrison, C., Wang, L., Xiong, D., Vedell, P., Cui, P., Hua, X., Ding, F., Lu, Y., James, M., Ebben, J. D., Xu, H., Adjei, A. A., Head, K., Andrae, J. W., Tschannen, M. R., Jacob, H., Pan, J., Zhang, Q., Van den Bergh, F., Xiao, H., Lo, K. C., Patel, J., Richmond, T., Watt, M.-A., Albert, T., Selzer, R., Anderson, M., Wang, J., Wang, Y., Starnes, S., Yang, P., & You, M.
Venue
Carcinogenesis
Published
2012-04-17
Volume
33
Issue
7
Pages
1270-1276
ISSN
  • 0143-3334 (ISSN-L)
  • 1460-2180
OpenAlex
W2097238709
Cited by
205
References
7
FWCI
19.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. https://app.cochat.ai/papers/10.1093/carcin/bgs148
The paper
Liu, P., Morrison, C., Wang, L., Xiong, D., Vedell, P., Cui, P., Hua, X., Ding, F., Lu, Y., James, M., Ebben, J. D., Xu, H., Adjei, A. A., Head, K., Andrae, J. W., Tschannen, M. R., Jacob, H., Pan, J., Zhang, Q., . . . You, M. (2012). Identification of somatic mutations in non-small cell lung carcinomas using whole-exome sequencing. Carcinogenesis. https://doi.org/10.1093/carcin/bgs148

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.